User menu

Rash as a marker for the efficacy of gemcitabine plus erlotinib-based therapy in pancreatic cancer: Results from the AViTA Study

Bibliographic reference Verslype, Chris ; Vervenne, Walter L ; Bennouna, Jaafar ; Humblet, Yves ; Cosaert, Jan ; et. al. Rash as a marker for the efficacy of gemcitabine plus erlotinib-based therapy in pancreatic cancer: Results from the AViTA Study.45th Annual Meeting of the American-Society-of-Clinical-Oncology ((United States) Orlando, FL, du 29/05/2009 au 02/06/2009). In: Journal of Clinical Oncology, Vol. 27, no. 15 Suppl, p. abstr 4532 (2009)
Permanent URL http://hdl.handle.net/2078.1/58675